Tirzepatide
FDA ApprovedTirzepatide (LY3298176)
- Category
- Weight Loss & Metabolism
- Aliases
- Mounjaro, Zepbound, LY3298176
- Administration
- Subcutaneous injection (once weekly)
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
1–2 Weeks
Appetite changes are usually the first thing users notice, often described as feeling full sooner during meals.
- 2
3–4 Weeks
Reduced hunger between meals may become more consistent as the dose is titrated upward.
- 3
5–7 Weeks
Early, gradual weight changes may start to become noticeable to the user.
- 4
8–10 Weeks
Clothing fit and energy levels are commonly the next things users report changing.
- 5
11–15 Weeks
Appetite suppression and weight-change trends typically continue at a steady pace.
- 6
16–20 Weeks
Many users describe this stage as when the changes become visually apparent to others.
- 7
21–24 Weeks
By this point, many users are approaching or maintaining a new, more stable dose and eating pattern.
⚠️ Research context only. This is not medical advice and results are not guaranteed.